The study found that IGHG1 was highly expressed in tumors such as ovarian cancer, and participates in pathological processes such as EMT, proliferation, apoptosis resistance, immune escape and metastasis of tumor cells 6, 7. Here, IGHG1 is linked to ovarian carcinoma.